ComPro Pharma: sector benchmark
Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.
ComPro Pharma
Summary
ComPro Pharma does better than half of its sector on 5 of the 10 ratios compared.
- Return on equitybetter than 95%
- Return on assetsbetter than 95%
- Interest coveragebetter than 89%
- Debt to equitybetter than 8%
- Working-capital ratiobetter than 10%
- Current ratiobetter than 14%
Solvency and debt
Solvency is below 80% of 912 sector peers: in the least favourable quarter.
Position against the sector weakening since 2021.
Debt to equity is above 92% of 902 sector peers: in the least favourable quarter.
Position against the sector weakening since 2021.
Interest coverage is above 89% of 805 sector peers: in the most favourable quarter.
Liquidity
The current ratio is below 86% of 889 sector peers: in the least favourable quarter.
Position against the sector weakening since 2021.
The working-capital ratio is below 90% of 911 sector peers: in the least favourable quarter.
Position against the sector weakening since 2021.
Profitability
Return on equity is above 95% of 773 sector peers: in the most favourable quarter.
Position against the sector stable since 2021.
Return on assets is above 95% of 910 sector peers: in the most favourable quarter.
Position against the sector stable since 2021.
The net margin is above 88% of 115 sector peers: in the most favourable quarter.
Position against the sector stable since 2021.
The gross margin is below 62% of 99 sector peers: less favourable than the median.
Position against the sector stable since 2021.
Working-capital cycle
Days sales outstanding is below 85% of 116 sector peers: in the most favourable quarter.
Position against the sector stable since 2021.
Days payable outstanding is below 95% of 117 sector peers.
Not computable
Long-term debt ratio, EBITDA margin, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.
Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 29 September 2026 via checked.be.